Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide

Pakistan Journal of Pharmaceutical Sciences

Volumn 24, Issue 3, 2011, Pages 399-404

  Ahad, Hindustan Abdul ^a   Kumar, Chitta Suresh ^a   Budideti, Kishore Kumar Reddy ^a   Battula, Suma Padmaja ^a   Ayyavala, Chandra Sekhar ^a  

^a SRI KRISHNADEVARAYA UNIVERSITY   (India)

Author keywords

Ficus glomerata; Gliclazide; Matrix tablets; Sustained release

Indexed keywords

GLICLAZIDE;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SCREENING; DRUG STABILITY; FICUS; FICUS GLOMERATA; IN VITRO STUDY; INFRARED SPECTROSCOPY; MATRIX TABLET; MUCILAGE; NONHUMAN; SUSTAINED RELEASE FORMULATION;

ADHESIVES; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG EVALUATION, PRECLINICAL; DRUG STABILITY; EXCIPIENTS; FICUS; GLICLAZIDE; MECHANICAL PHENOMENA; MODELS, STATISTICAL; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TABLETS;

EID: 79959955513     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Baveja SK, Rao KV and Arora J (1988). Examination of natural mucilages as sustaining agents in tablet dosage forms. Indian J. Pharm. Sci. 50(2): 89-92.
2. Bhardwaj TR, Kanwar M and Lal R (2000). Natural gums and modified natural gums as sustained release carriers. Drug Dev. Ind. Pharm., 26: 1025-1038.
3. Braby, Michael F (2005). The complete field guide to butterflies of Australia. Collingwood, Victoria: CSIRO Publishing, p.194.
4. Carr RL (1965). Evaluating flow properties of solids, Chem. Eng. 72: 163-168.
5. Carter SJ (1986). Tutorial Pharmacy, CBS Publishers and Distributors, New Delhi, India, pp.211-233.
6. Desai A, Shidhaye S and Malke S (2005). Use of natural release retardant in drug delivery system. Indian Drugs, 42: 565-575.
7. Dollery SC (1991). Therapeutic Drugs. Churchill Livingstone, London, p.A21.
8. Indian Pharmacopoeia (2007). Controller of Publications, Ministry of Health and Family Welfare, Government of India, New Delhi.
9. Killedar SG, Bhagwat DA, Adnaik RS, More HN and D'souza JI (2008). optimization of method for determination of swelling factor of Ispaghula seeds. Indian Drugs, 45(4): 310-313.
10. Kulkarni GT, Gowthamarajan K, Rao BG and Suresh B (2002). Evaluation of binding properties of selected natural graecum mucilages. Indian Drugs, 39: 422-425. (Pubitemid 39610544)
11. Lachman L, Lieberman HA and Kanig JL (1986). The Theory and Practice of Industrial Pharmacy. 3rd ed., Lea & Febiger, Philadelphia, PA, pp.293-45.
12. Mark Woolfe L, Martin Chapli F and Gifty Otchere (1917). Studies on the Mucilages Extracted from Okra Fruits (Hibiscus esculentus L.) and Baobab Leaves (Adansonia digitata L.), J. Sci. Fd Agric. 28:519-529.
13. Martin A (2001). Physical Pharmacy: Lippincott Williams & Wilkins, Baltimore, MD, pp.423-454.
14. nd ed. The Pharmaceutical Press, London.
15. Stephen M and Churms SC (2006). Introduction. In: Food Polysaccharides and their Application. Edi., AM Stephen, GO Phillips PA Williams. Taylor and Francies, CRC Press, New York, pp.1-24.
16. th ed, McGraw-Hill, New York, p.1484.
17. Timko, RJ and Lordi NG (1978). In vitro evaluation of three commercial sustained release papaverine hydrochloride products, J. Pharm. Sci., 67: 496.
18. th ed. Medical Publishers (Pvt.) Ltd, New Delhi, pp.142-44.
19. United States Pharmacopoeia 24, NF 19 (2000). United States Pharmacopoeial Convention, Rockville, M.D. Asian Edi., 1462-5, pp.1913-1914.